Instil Bio, Inc.

NASDAQ:TIL

66.1 (USD) • At close September 18, 2024
Bedrijfsnaam Instil Bio, Inc.
Symbool TIL
Munteenheid USD
Prijs 66.1
Beurswaarde 429,908,451
Dividendpercentage 0%
52-weken bereik 6.08 - 92
Industrie Biotechnology
Sector Healthcare
CEO Mr. Bronson Crouch
Website https://instilbio.com

An error occurred while fetching data.

Over Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and

Vergelijkbare Aandelen

Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

ALLO

2.88 USD

SomaLogic, Inc. logo

SomaLogic, Inc.

SLGC

2.1 USD

Celularity Inc. logo

Celularity Inc.

CELU

2.56 USD

Innoviva, Inc. logo

Innoviva, Inc.

INVA

19.54 USD

Adaptive Biotechnologies Corporation logo

Adaptive Biotechnologies Corporation

ADPT

4.61 USD

Silk Road Medical, Inc logo

Silk Road Medical, Inc

SILK

27.49 USD

Cassava Sciences, Inc. logo

Cassava Sciences, Inc.

SAVA

30.32 USD

NGM Biopharmaceuticals, Inc. logo

NGM Biopharmaceuticals, Inc.

NGM

1.54 USD

Agios Pharmaceuticals, Inc. logo

Agios Pharmaceuticals, Inc.

AGIO

45.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)